• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORDIS US CORP. SMART CONTROL; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORDIS US CORP. SMART CONTROL; STENT, ILIAC Back to Search Results
Catalog Number C08060MV
Device Problem Fracture (1260)
Patient Problem Swelling/ Edema (4577)
Event Date 09/02/2023
Event Type  Injury  
Event Description
As reported, a 120cm 8 x 80mm smart vascular stent system was found fractured and the patient presented with abdominal distension and fever several months after implantation of the stent.The patient had originally undergone percutaneous hepatic perforation biliary stenting.The stent was implanted under digital subtraction angiography (dsa) guidance, and the stent was opened completely and positioned accurately.An 8f biliary drain was placed at the proximal end of the stent, and the drainage was smooth.After "fixation", the patient was sent back to the ward and was discharged with improvement.Months later, the patient was hospitalized for "abdominal distension with fever for 2 days", and a chest ct revealed a fractured nickel-titanium stent.It was difficult to remove the stent surgically.The remained in the patient's body.The cause of the fracture was unknown.The combination of biliary obstruction and infection is clear.The patient was treated with anti-infection, hepatoprotective, choleretic regimens, as well as rehydration measures.The patient's vitals have been closely monitored.This has been an isolated case.The surgery was routine.The surgeon was a skilled person.The patient had no falls or impacts.The device was not returned for evaluation.
 
Manufacturer Narrative
Additional information is pending and will be submitted within 30 days upon receipt.
 
Manufacturer Narrative
Complaint conclusion: a 120cm 8 x 80mm smart vascular stent system was found fractured and the patient presented with abdominal distension and fever several months after implantation of the stent.The patient had originally undergone percutaneous hepatic perforation biliary stenting.The stent was implanted under digital subtraction angiography (dsa) guidance, and the stent was opened completely and positioned accurately.An 8f biliary drain was placed at the proximal end of the stent, and the drainage was smooth.After "fixation", the patient was sent back to the ward and was discharged with improvement.Months later, the patient was hospitalized for "abdominal distension with fever for 2 days", and a chest ct revealed a fractured nickel-titanium stent.It was difficult to remove the stent surgically.The remained in the patient's body.The cause of the fracture was unknown.The combination of biliary obstruction and infection is clear.The patient was treated with anti-infection, hepatoprotective, choleretic regimens, as well as rehydration measures.The patient's vitals have been closely monitored.This has been an isolated case.The surgery was routine.The surgeon was a skilled person.The patient had no falls or impacts.Without the return of the device for analysis and based on the information provided, the reported ¿stent- fractured¿ could not be confirmed and the exact root cause could not be determined.According to the instructions for use ¿care should also be taken when deploying the stent as excessive force could, in rare instances, lead to stent deformation and/or fracture.Examine the device for any damage.If it is suspected that the sterility or performance of the device has been compromised, the device should not be used.Evaluate the distal end of the catheter to ensure that the stent is contained within the outer sheath.Do not use if the stent is partially deployed.Note: if resistance is met during delivery system introduction, the system should be withdrawn, and another system should be used.¿ stent fractures are a well-known potential complication of this type of procedure and are listed in the ifu as such.Fracture of self-expanding stents occurs in approximately 5% of the cases.Stenting in chronic occlusion represents an increased risk factor for fracture.The reported fever and swelling occurred several months after implantation of the stent.No corrective or preventive actions will be taken.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SMART CONTROL
Type of Device
STENT, ILIAC
Manufacturer (Section D)
CORDIS US CORP.
14021 nw 60 avenue
miami lakes, florida 33014
Manufacturer (Section G)
CORDIS US CORP.
14201 nw 60 avenue
miami lakes, florida 33014
Manufacturer Contact
karla castro
santiago troncoso 808
juarez, chihuahua 
7863138372
MDR Report Key18084978
MDR Text Key327540972
Report Number9616099-2023-06626
Device Sequence Number1
Product Code NIO
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
UNKNOWN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/10/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2024
Device Catalogue NumberC08060MV
Device Lot Number18119908
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 10/13/2023
Initial Date FDA Received11/07/2023
Supplement Dates Manufacturer Received11/08/2023
Supplement Dates FDA Received11/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/20/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
-
-